| Literature DB >> 28667011 |
Katharina Fleischhauer1,2, Bronwen E Shaw3.
Abstract
When considering HLA-matched hematopoietic cell transplantation (HCT), sibling and unrelated donors (UDs) are biologically different because UD-HCT is typically performed across HLA-DP disparities absent in sibling HCT. Mismatched HLA-DP is targeted by direct alloreactive T cell responses with important implications for graft-versus-host disease and graft-versus-leukemia. This concise review details special features of HLA-DP as model antigens for clinically permissive mismatches mediating limited T-cell alloreactivity with minimal toxicity, and describes future avenues for their exploitation in cellular immunotherapy of malignant blood disorders.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28667011 DOI: 10.1182/blood-2017-03-742346
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113